- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 46.738 ↑ 1.45%
[as on 6 May, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Mirae Asset Healthcare Fund Direct Growth and its peers as on 6 May, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | 8.32% | 77.37% | 27.95% | -10.87% | 36.86% | 41.36% | -2.65% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|
| Returns | 4.44% | -1.25% | -0.93% | 1.89% | -0.38% | -0.71% | -5.19% | 7.4% | -3.5% | 6.96% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 14.77% | 5.14% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.92% |
0.01% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.07% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.20% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.93% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.94% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 6.88% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.15% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 5.06% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.32% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.31% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 3.73% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.56% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.44% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.37% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.32% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.26% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.25% |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.03% |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 2.91% |
| Eris Lifesciences Ltd. | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 2.67% |
| Dr. Lal Path labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 1.95% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.88% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.67% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.27% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.25% |
| Narayana Hrudayalaya Ltd. | NH (INE410P01011) | Healthcare Services | 1.17% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 1.11% |
| Rubicon Research Ltd. | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 0.85% |
| Sagility Ltd. | SAGILITY (INE0W2G01015) | IT - Services | 0.54% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 0.49% |
| Sudeep Pharma Ltd. | INE0QPI01025 | Pharmaceuticals & Biotechnology | 0.44% |
| Deepak Nitrite Ltd. | DEEPAKNTR (INE288B01029) | Chemicals & Petrochemicals | 0.43% |
| Neogen Chemicals Ltd. | NEOGEN (INE136S01016) | Chemicals & Petrochemicals | 0.42% |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 0.09% |
Debt
| Name | Rating | Weight % |
|---|
| Mirae Asset Liquid Fund-Direct Plan-Growth | | 0.01% |
Portfolio data is as on date 31 March, 2026
NAV history
Mirae Asset Healthcare Fund Direct Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 6 May, 2026 | 46.738 | 1.45% |
| 5 May, 2026 | 46.070 | 0.17% |
| 4 May, 2026 | 45.991 | 1.61% |
| 30 April, 2026 | 45.264 | -0.2% |
| 29 April, 2026 | 45.353 | 0.18% |
| 28 April, 2026 | 45.270 | -0.3% |
| 27 April, 2026 | 45.408 | 2.09% |
| 24 April, 2026 | 44.477 | -1.14% |
| 23 April, 2026 | 44.990 | 1.8% |
| 22 April, 2026 | 44.193 | 0.37% |
| 21 April, 2026 | 44.031 | 0.26% |
| 20 April, 2026 | 43.918 | -0.22% |
| 17 April, 2026 | 44.015 | 0.56% |
| 16 April, 2026 | 43.769 | -0.09% |
| 15 April, 2026 | 43.808 | 1.79% |
| 13 April, 2026 | 43.037 | -0.16% |
| 10 April, 2026 | 43.108 | 0.6% |
| 9 April, 2026 | 42.850 | 0.77% |
| 8 April, 2026 | 42.521 | 0.9% |
| 7 April, 2026 | 42.143 | 0.18% |
| 6 April, 2026 | 42.069 | 0.27% |
| 2 April, 2026 | 41.957 | -0.85% |
| 1 April, 2026 | 42.317 | -0.64% |
| 31 March, 2026 | 42.590 | 0% |
| 30 March, 2026 | 42.591 | -1.3% |
| 27 March, 2026 | 43.153 | -0.26% |
| 25 March, 2026 | 43.265 | 2.02% |
| 24 March, 2026 | 42.410 | 0.82% |
| 23 March, 2026 | 42.067 | -2.19% |
| 20 March, 2026 | 43.007 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 46.738 as on 6 May, 2026.
What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 9.33% as on 6 May, 2026.
What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 15.51% as on 6 May, 2026.
What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 27.1% as on 6 May, 2026.
What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 16.34% as on 6 May, 2026.
